Clinical Trial Update: The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms [Phase 1]

View source ↗

Summary

Phase 1 clinical trial from Mayo Clinic evaluating the cognitive effects of lorazepam in healthy older adults with TOMM40 polymorphisms, in the context of Alzhe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lorazepam (Ativan) (Lorazepam)

Snippet

Sponsor: Mayo Clinic | Conditions: Alzheimer's Disease (AD) | Phase 1 | Status: COMPLETED